Modified Atkins Diet and Type 2 Diabetic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00552890
Recruitment Status : Completed
First Posted : November 2, 2007
Last Update Posted : November 2, 2007
Information provided by:
Hadassah Medical Organization

November 1, 2007
November 2, 2007
November 2, 2007
December 2001
Not Provided
weight loss and glucose control [ Time Frame: 1 year ]
Same as current
No Changes Posted
lipid profile, kidney function [ Time Frame: 1 year ]
Same as current
Not Provided
Not Provided
Modified Atkins Diet and Type 2 Diabetic Patients
Influende of a Modified Atkins Diet on Glucose Metabolism and Weight Loss in Obese Type 2 Diabetic Patients - A Randomized Controlled Trial
This randomized control trial compared the influence of an Atkins diet to that of the ADA recommended diet on Type 2 diabetic obese patients during a one-year follow-up period
Not Provided
Not Applicable
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Obese Type 2 Diabetic Patients
  • Other: modified Atkins diet
    subjects assigned to follow modified Atkins diet for 1 year
  • Other: ADA recommended diet
    subjects assigned to follow ADA recommended diet for period of 1 year
  • Experimental: ATK
    modified Atkins diet
    Intervention: Other: modified Atkins diet
  • Experimental: ADA
    subjects assigned to follow ADA recommended diet for 1 year
    Intervention: Other: ADA recommended diet
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Same as current
February 2004
Not Provided

Inclusion Criteria:

  • Type 2 diabetic patients age 35-75 years
  • BMI 30-39.9kg/m
  • HbA1C>7%
  • Not receiving insulin
  • Micro-albumin excretion<60 mg/day

Exclusion Criteria:

  • Serum creatinine level > 1.4 mg per deciliter
  • Diastolic blood pressure > 100 mmHg or systolic blood pressure > 180mmHg
  • Liver disease
  • LDL cholesterol > 160 mg per deciliter despite lipid-lowering treatment
  • Use of psychiatric medications
  • Osteoporosis
  • Cancer
  • Food allergies, and
  • Low carbohydrate diet in the past 6 months.
Sexes Eligible for Study: All
35 Years to 75 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Not Provided
Hadassah Medical Organization
Not Provided
Principal Investigator: Itamar Raz, MD Director, Diabetes Unit, Hadassah University Hospital
Hadassah Medical Organization
December 2001

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP